We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Antihyperglykämische Therapie bei Diabetes mellitus Typ 2 (Update 2019).
- Authors
Clodi, Martin; Abrahamian, Heidemarie; Brath, Helmut; Brix, Johanna; Drexel, Heinz; Fasching, Peter; Föger, Bernhard; Francesconi, Claudia; Fröhlich-Reiterer, Elke; Harreiter, Jürgen; Hofer, Sabine E.; Hoppichler, Friedrich; Huber, Joakim; Kaser, Susanne; Kautzky-Willer, Alexandra; Lechleitner, Monika; Ludvik, Bernhard; Luger, Anton; Mader, Julia K.; Paulweber, Bernhard
- Abstract
Summary: Hyperglycemia significantly contributes to complications in patients with diabetes mellitus. While lifestyle interventions remain cornerstones of disease prevention and treatment, most patients with type 2 diabetes will eventually require pharmacotherapy for glycemic control. The definition of individual targets regarding optimal therapeutic efficacy and safety as well as cardiovascular effects is of great importance. In this guideline we present the most current evidence-based best clinical practice data for healthcare professionals.
- Subjects
MEDICAL personnel; TYPE 2 diabetes; GLYCEMIC control; DIABETES; THERAPEUTICS
- Publication
Wiener Klinische Wochenschrift, 2019, Vol 131, p27
- ISSN
0043-5325
- Publication type
Article
- DOI
10.1007/s00508-019-1471-z